Thursday, May 17, 2012
Recent studies might suggest an increase of Type 2 diabetes among children and young adults, but the real low hanging fruit, according to diabetes and policy experts, may be among the Medicare population.
Those 65 and older tend to be a costly population for health care services, according to Matthew Mawby, the government affairs officer for drugmaker Novo Nordisk. Intervention and prevention programs for pre-diabetics could be a more effective means of care, Mawby said during a policy panel on Tuesday.
Continue Reading -
Targeting Diabetes Prevention Among Medicare Beneficiaries – Capsules - The KHN Blog